Internal Deadline: October 1, 2021, 5pm PT
LOI: October 18, 2021
External Deadline: November 18, 2021
Award Type: Grant
Estimated Number of Awards: 3
Anticipated Award Amount: $2.63 million
Who May Serve as PI: The PCEN Director must be an established investigator with demonstrated research accomplishments and prior success in obtaining external funding.
Process for Limited Submissions
PIs must submit their application as a Limited Submission through the Office of Research Application Portal: https://orif.usc.edu/oor-portal/.
Materials to submit include:
- (1) Single Page Proposal Summary (0.5” margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 1-page limit will be excluded from review.
- (2) CV – (5 pages maximum)
Note: The portal requires information about the PIs and Co-PIs in addition to department and contact information, including the 10-digit USC ID#, Gender, and Ethnicity. Please have this material prepared before beginning this application.
The goals of the PCEN program are: 1. to attract new scientific expertise to the study of human pediatric renal physiology, kidney development, and pediatric kidney disorders; 2. to encourage multidisciplinary research in these areas; and 3. to develop the pediatric nephrology research community through a national research symposium, broad sharing of research resources, and a national Pilot and Feasibility grant program. These efforts are expected to lead to innovative approaches to study kidney disease in children and the eventual submission of substantial, competitive, investigator–initiated research applications. The PCEN will complement the O’Brien Kidney and Urological Research Centers and are expected to leverage existing institutional resources which may include Clinical Translational Science Awards, Institutional Network Awards for Promoting Kidney, Urologic, and Hematologic Research Training (U2C/TL1), and other KUH-funded consortia. It is anticipated that collaboration will occur among individuals in the clinical and basic sciences, including cell biology, molecular biology, immunology, genetics, epidemiology, biochemistry, physiology and pathology. Resources and studies that foster new approaches into the causes, early diagnoses and treatments, and where possible, prevention of these diseases and disorders are appropriate.
Each Center within the PCEN program will be thematically distinct, yet complementary to the national network of PCEN. The Centers will jointly arrange and sponsor a yearly, open, broadly advertised, scientific symposium featuring the research projects and biomedical cores at each site in the Bethesda MD/Washington DC area. Junior faculty will be particularly encouraged to present their work. Pilot and Feasibility awardees will present the results of their funded projects. (Further details provided below under Educational Enrichment activities).
The Pilot and Feasibility project application processes will be coordinated between Centers to avoid unnecessary duplication or conflicts and to attract and support the best people and ideas to further pediatric kidney research. (Further details provided below in section Pilot and Feasibility Program).
To promote collaboration, the PIs/PDs of each of the PCEN will have conference calls at least quarterly, joined by NIDDK program staff. It is anticipated these conference calls will include planning for the yearly open scientific meeting, coordination of widely publicized announcements and NIH-style reviews of Pilot and Feasibility project applications, and should include sharing of progress on research projects.
Budgetary Requirements: This FOA does not require cost sharing as defined in the NIH Grants Policy Statement.
Visit our Institutionally Limited Submission webpage for more updates and other announcements.